Legal Representation
Attorney
Barry F. Soalt
USPTO Deadlines
Next Renewal Deadline
Non-Final Action Mailed
Due: August 16, 2025
(40 days remaining)
Extension available until: November 16, 2025
Additional renewal deadlines exist. Contact your attorney for complete deadline information.
Application History
6 eventsDate | Code | Type | Description |
---|---|---|---|
May 16, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
May 16, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
May 16, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
May 9, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
May 8, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Nov 14, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Medical diagnostic reagents and assays for testing of bodily fluids for use in detection of any disease or condition where it is desired to detect specific nucleic acids or derivatives thereof, namely, cancer, infectious disease, inherited genetic disease, somatic aberration, and rejection of transplanted organs; drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of gene events, namely, mutations, single nucleotide polymorphisms (SNP's) and other disease biomarkers, translocations, deletions, gene copy number changes, RNA expression levels, and biomarkers specific to disease conditions; drug testing kits comprised of medical diagnostic reagents and assays, test strips, test patches, and test media for various medical purposes
Class 010
Medical diagnostic apparatus, instruments for testing DNA and RNA and diagnostic testing for the interrogation of DNA and RNA nucleic acids for any disease or condition where it is desired to detect specific nucleic acids or derivative thereof, namely, cancer, an infectious disease, inherited genetic disease, somatic aberration, and rejection of transplanted organs
Class 042
Medical, scientific and clinical research in the fields of diagnostics, genomics, next generation sequencing (NGS) and therapeutics, molecular diagnostics for the detection of DNA and RNA targets of interest, Sanger sequencing, NGS, capillary electrophoresis, mass-spectral analysis, and microarray analysis
Class 044
Health assessment services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; and consulting services in the fields of diagnostic medical testing and treatment of diseases
Classification
International Classes
005
010
042
044